ArticleScientific reports2016

The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers.

Abdulraheem Alshareef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.